Mode of Spread in the Early Phase of Lymphatic Metastasis in Pancreatic Ductal Adenocarcinoma
- 1 December 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 240 (6) , 993-1001
- https://doi.org/10.1097/01.sla.0000145922.25106.e3
Abstract
Background: The aim of this study was to assess the prognostic significance of nodal microinvolvement as well as the mode of spread in the early phase of lymphatic metastasis in patients with node-negative pancreatic ductal adenocarcinoma. Methods: Lymph nodes from 48 node-negative patients with R0 resected pancreatic ductal adenocarcinoma were sampled from 3 different compartments: 1) distal hepatoduodenal ligament, 2) superior-anterior compartment, and 3) posterior-inferior. Tissue sections of 148 lymph nodes classified as tumor free by routine histopathology were examined, using a sensitive immunohistochemical assay with the antiepithelial monoclonal antibody Ber-EP4 for tumor cell detection. With regard to histopathologic tumor staging and grading, 26 (54.2%) of the patients were staged as pT1/pT2, 22 (45.8%) as pT3/pT4, while 31 (64.6%) as G1/G2 and 17 (35.4%) patients as G3. Of the 148 “tumor free” lymph nodes, 56 contained Ber-EP4–positive tumor cells. These 56 lymph nodes were from 28 of the 48 patients. The multivariate Cox regression analysis revealed the independent prognostic impact of nodal microinvolvement on relapse-free and overall survival. Analysis by compartment, from which the lymph nodes were collected, revealed that overall survival time (P = 0.006) and time to local recurrence (P = 0.015) depend on the presence of nodal microinvolvement in the superior-anterior compartment. Conclusions: The influence of occult tumor cell dissemination in lymph nodes of patients with histologically proven pancreatic ductal adenocarcinoma supports the need for further tumor staging through immunohistochemistry. This could be a helpful tool in proper selection of patients for adjuvant chemotherapy.Keywords
This publication has 36 references indexed in Scilit:
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- A Surgical and Pathological Based Classification of Resective Treatment of Pancreatic CancerDigestive Surgery, 1999
- Early Lymphatic Tumor Cell Dissemination in Pancreatic CancerPancreas, 1997
- Long-Term Survival After Resection for Ductal Adenocarcinoma of the Pancreas Is It Really Improving?Annals of Surgery, 1995
- Methodological Analysis of Immunocytochemical Screening for Disseminated Epithelial Tumor Cells in Bone MarrowJournal of Hematotherapy, 1994
- Frequency and Distribution of Occult Micrometastases in Lymph Nodes of Patients With Non-Small-Cell Lung CarcinomaJNCI Journal of the National Cancer Institute, 1993
- Survival After PancreatoduodenectomyAnnals of Surgery, 1990
- Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial.Journal of Clinical Pathology, 1990
- Histological evaluation of three new monoclonal anti-cytokeratin antibodies. 1. Normal tissuesEuropean Journal of Cancer and Clinical Oncology, 1987
- Results of Resection in Non-Oat Cell Carcinoma of the Lung with Mediastinal Lymph Node MetastasesAnnals of Surgery, 1983